Document Detail

Vaginal Misoprostol for Cervical Priming before Gynaecological Procedures on Non Pregnant Women.
MedLine Citation:
PMID:  21475427     Owner:  NLM     Status:  PubMed-not-MEDLINE    
BACKGROUND: Misoprostol has been extensively researched for its use in obstetrics and has proved to be a very effective cervical softening agent before termination of pregnancy. The beneficial effects on cervical ripening may make misoprostol a desirable agent for helping cervical dilatation on non pregnant women also. The objective is to study the efficacy of preoperative vaginal application of misoprostol as cervical priming agent before gynaecological procedures on non pregnant women.
DESIGN: A randomized controlled trial.
SETTING: Department of Gynaecology and Obstetrics of two medical colleges.
PARTICIPANTS: 468 non pregnant pre-menopausal nulli-parous or parous women scheduled to have diagnostic D&C or diagnostic hysteroscopy operations.
INTERVENTIONS: 400 mcg intravaginal misoprostol (229 women) in the study group and 400 mg intravaginal metronidazole as placebo (231 women) in control group.
OUTCOME MEASURE: The main outcome measures were baseline cervical width at the beginning of the procedures, the number of women who required further cervical dilatation, time taken for dilatation, side effects and other complications.
RESULTS: Base line cervical width in the study group was significantly higher than control group (4.6±0.8 mm vs. 3.8±0.7 mm, p < 0.0001). 141 (61.57%) cases required further cervical dilatation in the study group compared to 206 (89.18%) in the control group (p < 0.0001). Time taken for further cervical dilatation was significantly lower in the study group compared to control group (48.3±18.4 sec vs. 68.6±17.3 sec, p < 0.0001). Cervical injury and uterine perforation occurred in 12 and 3 women respectively in the control group compared to 1 and 0 women respectively in the misoprostol group. Two most common side effects of vaginal misoprostol were mild lower abdominal pain (21%) and slight vaginal bleeding (09.2%) which were within tolerable limit.
CONCLUSION: Preoperative vaginal application of misoprostol before gynaecological procedures on non pregnant women decreases the cervical resistance, facilitates the cervical dilatation and operative procedures minimizing cervical or uterine injuries.
Shyama Prasad Saha; Nabendu Bhattacharjee; Gangotri Baru
Related Documents :
22151157 - Community screening for cardiovascular risk factors and levels of treatment in a rural ...
11083317 - Stepping performance during obstacle clearance in women: age differences and the associ...
16966927 - Cardiovascular disease risk reduction in older adults.
2052997 - Back sprain in industry. the role of socioeconomic factors in chronicity.
11578297 - Small bowel obstruction after appendicectomy.
14535597 - Racial/ethnic differences in the self-reported use of screening mammography.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of health sciences     Volume:  1     ISSN:  1658-3639     ISO Abbreviation:  Int J Health Sci (Qassim)     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2011-04-08     Completed Date:  2011-07-14     Revised Date:  2011-10-21    
Medline Journal Info:
Nlm Unique ID:  101528042     Medline TA:  Int J Health Sci (Qassim)     Country:  Saudi Arabia    
Other Details:
Languages:  eng     Pagination:  185-93     Citation Subset:  -    
Deptt. of Obst. & Gyne, North Bengal Medical College, Darjeeling, West Bengal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Association of Beta-catenin Gene Mutations and Human Papillomavirus in Carcinoma of Esophagus in...
Next Document:  Immunohistochemical detection of HCV in nerves and muscles of patients with HCV associated periphera...